Evommune Ratios (2024-2026) | EVMN

Ratios Sep2024 Dec2024 Mar2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -481.07%-124.75%
EBIT Margin (Quarter) -501.07%-133.28%
EBITDA Margin (Quarter) -501.07%-133.28%
Operating Margin (Quarter) -501.07%-133.28%
Net Margin (Quarter) -481.07%-124.75%
FCF Margin (Quarter) -796.63%
Efficiency
Assets Average (Quarter) 154.75M273.70M
Equity Average (Quarter) -133.38M-151.24M-170.69M11.21M255.06M
Invested Capital (Quarter) -122.53M-144.24M-158.24M-183.14M205.57M304.56M
Asset Utilization Ratio (Quarter) 0.080.05
Leverage & Solvency
Interest Coverage Ratio (Quarter) -971.590.02M-0.00M-0.00M-0.01M
Equity Ratio (Quarter) -1.90-2.170.910.94
Times Interest Earned (Quarter) -971.590.02M-0.00M-0.00M-0.01M
Valuation
Enterprise Value (Quarter) -18.15M-72.04M-5.70M-76.06M-149.20M-211.46M
Return Ratios
Return on Sales (Quarter) -0.05%-0.01%-0.06%-0.06%
Return on Capital Employed (Quarter) -58.12%-31.18%
Return on Assets (Quarter) 0.00%0.00%
Return on Equity (Quarter) 0.00%-0.07%0.00%